Bio-Rad Laboratories (BIO) Net Margin Growth (1y) (2010 - 2026)
Bio-Rad Laboratories (BIO) Net Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 656.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 201.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -430.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bio-Rad Laboratories | 8.53 Bn | 6.97 Bn | 309.40 Mn | -9,995.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,995.00 |
| Dec 31, 2025 | 21,110.00 |
| Sep 30, 2025 | -15,290.00 |
| Jun 30, 2025 | 38,793.00 |
| Mar 31, 2025 | -5,192.00 |
| Dec 31, 2024 | -15,858.00 |
| Sep 30, 2024 | 8,373.00 |
| Jun 30, 2024 | -16,852.00 |
| Mar 31, 2024 | 5,266.00 |
| Dec 31, 2023 | -6,201.00 |
| Sep 30, 2023 | 4,072.00 |
| Jun 30, 2023 | -3,678.00 |
| Mar 31, 2023 | 49,117.00 |
| Dec 31, 2022 | 32,695.00 |
| Sep 30, 2022 | -54,975.00 |
| Jun 30, 2022 | -26,155.00 |
| Mar 31, 2022 | -61,546.00 |
| Dec 31, 2021 | -32,085.00 |
| Sep 30, 2021 | 32,271.00 |
| Jun 30, 2021 | -5,231.00 |